An automated p-suture hemostatic compression device for placenta accreta spectrum (PAS)
Patent Information
- Application Number
- IN202621025719
- Authority / Receiving Office
- IN · IN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2026-03-05
- Publication Date
- 2026-10-27
- Estimated Expiration
- 2046-03-05
AI Technical Summary
Conventional manual P-suture techniques for managing placenta accreta spectrum are highly operator-dependent, non-standardized, and technically demanding, leading to variations in needle angle, penetration depth, and suture tension, resulting in ineffective compression, tissue trauma, and increased procedural complexity, often necessitating emergency hysterectomy.
An automated P-suture hemostatic compression device with a filament delivery and routing assembly, bidirectional penetration guidance, depth-limiting elements, tension-regulating compression segment, anterior ligation and locking module, and actuation mechanism to standardize uterine compression suturing, reducing variability and procedural risk.
The device provides reproducible, controlled uterine compression suturing, minimizing operator dependence, preserving uterine anatomy, and reducing the need for hysterectomy, while ensuring effective hemorrhage control and improved maternal outcomes.
Abstract
Description
TECHNICAL FIELD
[0001] The present invention relates to the field of obstetric surgical devices and, more particularly, to an automated uterine compression and suturing apparatus for controlling postpartum hemorrhage associated with placenta accreta spectrum. The present invention specifically concerns a mechanically actuated P-suture hemostatic compression device configured to standardize and automate uterine wall approximation for hemorrhage control.BACKGROUND
[0002] Placenta accreta spectrum (PAS), including placenta accreta, increta, and percreta, is a life-threatening obstetric condition characterized by abnormal placental adherence and invasion into the uterine myometrium. Following delivery of the fetus, attempted placental separation in PAS cases exposes large placental bed sinusoids supplied by arcuate and spiral arterioles, resulting in rapid, uncontrolled uterine hemorrhage. Pharmacological uterotonics are frequently ineffective in such cases due to impaired uterine contractility at the placental implantation site, and emergency hysterectomy is often performed as a life-saving measure, leading to permanent loss of fertility and increased surgical morbidity.
[0003] Conventional conservative management relies on procedure for pernicious placenta previa (PPP) and certain new compression suture like P- suture, wherein a suture is passed through the lateral myometrial wall approximately one centimeter medial to the uterine border, directed from anterior to posterior on one side and posterior to anterior on the opposite side, and ligated anteriorly to approximate the anterior and posterior uterine walls. This compression collapses bleeding arcuate and spiral arterioles and provides effective hemostasis. Multiple such sutures may be applied from the lower uterine segment to the fundus, and additional cervical or encirclage-type sutures may be placed when bleeding extends to the cervix. However, successful execution of this technique requires high surgical expertise, precise depth control, appropriate force application, and careful avoidance of cornual regions, bladder injury, and uterine ischemia.
[0004] In real-world clinical settings, especially in peripheral or resource-limited hospitals, manual P-suture application is highly operator-dependent, non-standardized, and technically demanding. Variations in needle angle, penetration depth, suture tension, and knot security frequently result in ineffective compression, tissue trauma, endometrial perforation, uterine ischemia, or loosening of sutures after placental tissue removal. Moreover, repeated application of multiple sutures at different uterine levels further increases procedural complexity, operative time. As a result, many clinicians are compelled to proceed directly to hysterectomy despite the availability of uterus-preserving compression techniques.
[0005] Accordingly, there exists a critical and unmet technical need for a standardized, automated, and reproducible device capable of mechanically performing the P-suture compression pathway with controlled penetration depth, regulated compressive force, stable filament positioning, and secure anterior ligation, independent of surgeon-controlled suturing skill. Such a device is essential to enable rapid hemorrhage control, preserve uterine anatomy, reduce dependence on hysterectomy, facilitate safe patient stabilization and transfer from peripheral centers to tertiary hospitals, and improve overall maternal outcomes in placenta accreta spectrum cases.SUMMARY
[0006] In view of the limitations associated with conventional manual uterine compression suturing techniques used in the management of placenta accreta spectrum, the present invention provides an automated P-suture hemostatic compression suturing device structured to mechanically reproduce a standardized uterine compression pathway while reducing variability, technical dependence, and procedural risk inherent in surgeon-controlled suturing.
[0007] The present invention relates to an automated uterine compression suturing device comprising a filament delivery and routing assembly, a bidirectional penetration guidance mechanism, depth-limiting penetration elements, a tension-regulating compression segment, an anterior ligation and locking module, anchoring and alignment members, and an actuation mechanism operatively coupled thereto. The device is configured to deploy a biocompatible compression filament through lateral myometrial walls of a uterus in a predefined anterior-to-posterior and posterior-to-anterior pathway to form a P-suture compression loop, thereby approximating anterior and posterior uterine walls and compressing vascular structures associated with hemorrhagic placental bed regions.
[0008] The filament delivery and routing assembly guides the compression filament along a predefined lateral uterine entry trajectory at a location medial to the uterine border, while the bidirectional penetration guidance mechanism performs sequential penetration passes on opposite lateral uterine walls. The depth-limiting penetration elements mechanically and / or sensor-basedly restrict filament penetration to a controlled myometrial depth, thereby reducing the risk of endometrial or serosal perforation across variable uterine anatomies.
[0009] The tension-regulating compression segment applies a predefined compressive force sufficient to maintain uterine wall approximation while avoiding excessive tissue compression. The compression segment may include elastic buffering and force-limiting mechanisms configured to maintain substantially uniform compression despite uterine size variation or tissue compliance changes following placental tissue removal. The anterior ligation and locking module secure the compression filament at an anterior uterine surface and permits optional re-tightening where required.
[0010] The device may further comprise anchoring members configured to stabilize the compression filament along uterine curvature and alignment members configured to ensure symmetric placement of the compression loop. In certain embodiments, the device is configured to apply multiple P-suture compression loops at different uterine levels and to apply additional compression loops on cervical tissue using circular or encirclage-type pathways, thereby extending hemostatic coverage without reliance on repeated manual suturing.
[0011] The actuation mechanism may include a programmable controller, drive elements, and mechanical linkages configured to automatically execute filament deployment, penetration routing, compression tightening, and locking in a predefined sequence. Optional sensor systems provide feedback relating to penetration depth, tissue contact, or compression force, enabling real-time modulation of device operation to enhance procedural consistency and safety.
[0012] By integrating controlled filament routing, regulated penetration depth, standardized compression application, and automated ligation within a single surgical device, the present invention provides a reproducible mechanical approach to uterine compression suturing that is not achievable through conventional manual techniques. The cooperative interaction of the device components yields functional outcomes that cannot be derived from isolated suturing instruments or known compression methods, thereby enabling reliable hemorrhage control in placenta accreta spectrum with reduced dependence on surgeon-specific suturing skill.BRIEF DESCRIPTION OF DRAWINGS
[0013] FIG. 1 illustrates an automated P-suture hemostatic compression suturing device, in accordance with the present invention.
[0014] FIG. 2 illustrates an anatomical placement view of the automated P-suture hemostatic compression suturing device on a uterus, depicting the filament path, compression points, and associated control components, in accordance with the present invention.DETAILED DESCRIPTION
[0015] The present invention relates to an automated hemostatic compression suturing device for managing severe uterine hemorrhage associated with placenta accreta spectrum, particularly during or following cesarean delivery. Conventional manual P-sutures rely on repeated myometrial needle passes, with depth, orientation, and compression force determined by surgeon judgment, leading to variability, prolonged operative time, inadequate hemostasis, or excessive ischemia. These challenges are further exacerbated in emergency hemorrhage, limited surgical visibility, distorted uterine anatomy, or in cases requiring rapid intervention by less experienced operators.
[0016] The device automates critical steps of uterine compression suturing, including filament deployment, bidirectional penetration, controlled routing, tension-regulated compression, and anterior locking, forming standardized P-suture loops across lateral myometrial walls. Depth-limiting elements and, in certain embodiments, integrated sensors restrict filament passage within the myometrium, avoiding serosal or endometrial breach. The tension-regulating mechanism ensures repeatable compressive force sufficient to approximate anterior and posterior walls while preserving tissue viability, and stabilization features maintain symmetric loop placement along the uterine curvature, preventing migration or uneven pressure distribution. Multiple loops at different uterine levels, including encirclage-type cervical loops, provide comprehensive hemostatic coverage tailored to placental invasion.
[0017] Integrated sensor feedback dynamically monitors filament tension, penetration depth, tissue contact, and applied pressure, enabling real-time modulation to prevent over-compression or ischemic injury. Automated actuation executes a predefined operational sequence of deployment, routing, tightening, and locking, reducing procedural time and standardizing outcomes. Collectively, the device provides a reproducible, controlled, and efficient uterine compression system that minimizes operator dependence, preserves uterine integrity, and enables reliable hemostasis in life-threatening hemorrhagic scenarios associated with placenta accreta spectrum.
[0018] FIG. 1 illustrates an automated P-suture hemostatic compression device (100) for controlling uterine hemorrhage associated with placenta accreta spectrum, in accordance with the present invention. The device (100) is configured as an integrated surgical system designed to automate the placement of a standardized P-suture compression pathway across a uterus, thereby reducing dependence on manual suturing and improving consistency of hemostatic outcomes.
[0019] The device (100) comprises a filament delivery and routing assembly (102) configured to deploy a biocompatible compression filament (102-1) through lateral myometrial walls of the uterus at predefined anatomical locations. The filament delivery and routing assembly (102) includes a filament storage cartridge (102-2A) adapted to retain the compression filament (102-1) in a sterile and controlled manner prior to deployment. The filament storage cartridge (102-2A) ensures smooth filament dispensing without entanglement or irregular feed during operation.
[0020] The filament delivery and routing assembly (102) further comprises a guided filament conduit (102-2B) extending from the filament storage cartridge (102-2A) toward an exit nozzle (102-2C). The guided filament conduit (102-2B) is curved and dimensioned to follow a predefined lateral uterine entry trajectory, thereby ensuring that the compression filament (102-1) enters the myometrium at a controlled location approximately medial to a lateral uterine border. The exit nozzle (102-2C) is oriented to position the filament entry point with spatial precision, minimizing deviation from the intended penetration pathway.
[0021] A filament advancement drive (102-3) is operatively coupled to the filament delivery and routing assembly (102) and is configured to advance the compression filament (102-1) in controlled incremental lengths. The filament advancement drive (102-3) enables precise regulation of filament deployment during penetration, routing, and tightening stages, thereby preventing excessive filament feed and ensuring reproducible suture geometry.
[0022] The device (100) further includes a bidirectional penetration guidance mechanism (104) configured to automatically guide the compression filament (102-1) through the myometrium in opposing penetration directions on opposite lateral uterine walls. The bidirectional penetration guidance mechanism (104) comprises a reversible needle guide (104-1A) that defines the penetration axis and supports directional control during myometrial passage of the filament.
[0023] A directional switching cam (104-1B) is operatively associated with the reversible needle guide (104-1A) and is configured to automatically reverse the penetration orientation after completion of a first penetration pass. This enables the device (100) to perform an anterior-to-posterior penetration on one lateral uterine wall and a posterior-to-anterior penetration on the opposite lateral uterine wall, thereby forming the P-suture compression loop without requiring manual repositioning by the surgeon.
[0024] The bidirectional penetration guidance mechanism (104) further includes a penetration actuator (104-1C) configured to drive the reversible needle guide (104-1A) through the myometrium with controlled force and speed. The penetration actuator (104-1C) may be implemented using a linear drive (104-2A), a rotary cam (104-2B), or a pneumatic piston (104-2C), each selected to provide smooth, repeatable penetration motion while minimizing tissue trauma.
[0025] A plurality of depth-limiting penetration elements (106) is operatively associated with the bidirectional penetration guidance mechanism (104). The depth-limiting penetration elements (106) comprise penetration stop collars fixed to a needle shaft, wherein the penetration stop collars are configured to contact an outer uterine surface and mechanically restrict penetration depth. These penetrations stop collars are adjustable to accommodate variations in myometrial thickness across patients, thereby preventing unintended endometrial or serosal perforation.
[0026] In addition to mechanical depth limitation, the depth-limiting penetration elements (106) may further include sensor-based depth detection integrated with the penetration actuator (104-1C). Such sensor-based depth detection provides real-time feedback to ensure that penetration remains confined within the myometrial layer during filament passage.
[0027] The compression filament (102-1) deployed by the device (100) is selected from biocompatible materials including polyglactin, polydioxanone, polyglycolic acid, shape-memory alloy, or composite materials. The material selection enables sufficient tensile strength for compression while maintaining biocompatibility and, where required, absorbability within uterine tissue.
[0028] A tension-regulating compression segment (108) is integrated with the compression filament (102-1) and is configured to automatically apply a predefined compressive force to approximate anterior and posterior uterine walls. The tension-regulating compression segment (108) includes an elastic tension buffer configured to absorb excessive tightening force, thereby preventing sudden over-compression of uterine tissue. The tension-regulating compression segment (108) further includes a force-limiting clutch configured to disengage filament tightening when a preset compression threshold is reached. This ensures that compression sufficient to collapse arcuate and spiral arterioles at hemorrhagic placental bed regions is achieved without inducing ischemic injury. The compression segment (108) is further configured to maintain substantially constant compression despite uterine size variation or postoperative uterine involution.
[0029] An anterior ligation and locking module (110) are provided to automatically secure the compression filament (102-1) at an anterior uterine surface after completion of the bidirectional filament pathway. The anterior ligation and locking module (110) comprise a filament clamp (110-1) configured to temporarily hold the filament during tightening.
[0030] A knot-forming guide (110-2) is operatively associated with the filament clamp (110-1) and is configured to direct the compression filament (102-1) into a predefined ligation loop. A locking latch (110-3) secures the ligated filament and prevents loosening during uterine contraction or manipulation. The anterior ligation and locking module (110) are further configured to permit selective re-tightening after placental tissue removal, allowing adaptive adjustment of compression.
[0031] Anchoring and alignment members (112) are provided to stabilize the compression filament (102-1) along uterine curvature and maintain uniform circumferential compression. The anchoring members comprise soft atraumatic pads configured to grip the uterine serosa without causing surface injury, while distributing compressive force evenly across the tissue. The alignment members comprise curved guide rails conforming to uterine curvature and configured to ensure symmetric placement of the P-suture compression loop on opposing lateral uterine walls. These alignment members prevent filament migration and uneven compression during tightening and postoperative uterine movement.
[0032] An actuation mechanism (114) is operatively coupled to the filament delivery and routing assembly (102), the bidirectional penetration guidance mechanism (104), and the tension-regulating compression segment (108). The actuation mechanism (114) comprises a programmable controller (114-1), a drive motor (114-2), and mechanical linkages (114-3).
[0033] The programmable controller (114-1) is configured to execute a predefined operational sequence comprising filament deployment, penetration, routing, tightening, and locking. The drive motor (114-2) supplies mechanical power to the penetration actuator (104-1C), filament advancement drive (102-3), and compression segment (108), while the mechanical linkages (114-3) transmit motion between the actuation components and the respective functional modules.
[0034] The device (100) may further comprise sensors (116) selected from pressure sensors (116-1), depth sensors (116-2), tissue contact sensors (116-3), strain gauges (116-4), or optical sensors (116-5). These sensors (116) provide feedback to the programmable controller (114-1) to dynamically regulate compression force and penetration depth in real time, and to prevent excessive tightening after placental tissue removal.
[0035] Accordingly, FIG. 1 depicts a fully integrated automated P-suture hemostatic compression suturing device capable of executing a standardized, controlled, and repeatable uterine compression procedure for effective hemorrhage control in placenta accreta spectrum cases.
[0036] FIG. 2 illustrates an anatomical placement view of the automated P-suture hemostatic compression device positioned on a uterus, showing standardized mechanical approximation achieved by the actuation mechanism (114), depth-limiting penetration elements (106), a tension-regulating compression segment (108), and anchoring and alignment members (112), in accordance with the present invention.
[0037] As shown in FIG. 2, the device is arranged on the uterus such that controlled approximation of the anterior and posterior uterine walls is achieved through standardized mechanical approximation performed by the actuation mechanism (114). The actuation mechanism (114) applies controlled and repeatable mechanical force to the compression filament pathway, thereby eliminating reliance on surgeon-controlled manual tightening and ensuring uniform approximation across hemorrhagic regions of the uterus.
[0038] A plurality of depth-limiting penetration elements (106) is positioned along the lateral uterine walls and are configured to restrict penetration of the compression filament to a predetermined myometrial depth. As illustrated, the depth-limiting penetration elements (106) mechanically abut the outer uterine surface during penetration, thereby preventing excessive advancement and avoiding inadvertent perforation of the endometrial cavity or uterine serosa. This controlled penetration ensures consistent placement of the compression pathway irrespective of anatomical variation in uterine wall thickness.
[0039] The device further includes a tension-regulating compression segment (108) disposed along the anterior uterine surface. The tension-regulating compression segment (108) is configured to apply and maintain a predefined compressive force sufficient to approximate the anterior and posterior uterine walls and compress bleeding vasculature at placental bed regions. As depicted, the compression segment (108) absorbs excess tightening force and limits applied compression to prevent tissue ischemia while maintaining effective hemostasis.
[0040] Anchoring and alignment members (112) are provided at external locations relative to the uterus to stabilize the compression pathway and maintain uniform circumferential compression. The anchoring and alignment members (112) secure the device against displacement during uterine manipulation or physiological contraction and ensure symmetric positioning of the compression pathway relative to the uterine midline.
[0041] Accordingly, FIG. 2 demonstrates the cooperative interaction of standardized mechanical approximation by the actuation mechanism (114), controlled penetration by the depth-limiting penetration elements (106), regulated compression by the tension-regulating compression segment (108), and positional stability provided by the anchoring and alignment members (112). This integrated configuration enables predictable uterine wall approximation and effective hemorrhage control in placenta accreta spectrum conditions.
[0042] The automated P-suture hemostatic compression suturing device may be implemented in various configurations without departing from the scope of the present invention. The filament delivery and routing assembly may comprise straight, curved, articulated, or flexible conduits configured to follow uterine anatomy, with filament advancement achieved through motor-driven rollers, lead screws, pneumatic drives, spring-biased mechanisms, or equivalent feed systems. Filament storage may be provided as a cartridge, spool, cassette, or preloaded sterile pack, and filament entry positioning may be fixed, adjustable, or guided using mechanical stops, alignment features, or visual indicators.
[0043] The compression filament may be formed from absorbable or non-absorbable polymers, monofilament or braided sutures, elastic or shape-memory materials, or composite filaments. The filament may have circular, flattened, braided, or textured cross-sections to enhance tissue engagement and distribute compressive forces, and may incorporate elastic segments, variable stiffness zones, or radiopaque markers depending on clinical requirements.
[0044] The bidirectional penetration guidance mechanism may employ straight or curved needles, cannulated or trocar-style penetrators, and blunt or sharpened tips, and may incorporate cams, gears, sliding guides, or articulated joints to achieve directional reversal. Penetration may be actuated by linear or rotary motors, pneumatic or hydraulic pistons, or mechanically biased plungers. Penetration depth may be limited using adjustable collars, telescopic sleeves, shoulder stops, compliant bumpers, spacer rings, or sensor-based depth detection, implemented mechanically, electronically, or in hybrid arrangements.
[0045] The tension-regulating compression segment may include elastic buffers, spring elements, clutch mechanisms, friction-based limiters, or servo-controlled tensioners configured to maintain compression at predefined thresholds. The anterior ligation and locking module may utilize clamps, clips, crimps, knots, self-locking loops, barbed retention elements, or sliding locks, and may permit reversible or incremental re-tightening. Anchoring and alignment members may comprise atraumatic pads, compliant grips, contour-matching guide rails, or articulated support structures configured to conform to uterine curvature and distribute compression uniformly.
[0046] The actuation mechanism may include electric or stepper motors, pneumatic or hydraulic pistons, mechanical linkages, or hybrid systems operating sequentially, in parallel, or conditionally, and may be powered by batteries, mains electricity, or stored mechanical energy. Sensors may include pressure, strain, force, depth, optical, or tissue-contact sensors, with feedback used for real-time regulation, safety cut-offs, alerts, or data logging. A control unit may be implemented as a programmable microcontroller, embedded processor, logic circuit, or mechanical sequencing module coordinating filament deployment, penetration routing, compression tightening, locking, and sensor feedback, with user input provided via buttons, dials, touch interfaces, or predefined operating modes.
[0047] The device may be supplied as a fully disposable sterile unit or as a sterile single-use kit compatible with a reusable actuation console, with sterility achieved through gamma irradiation, ethylene oxide sterilization, or other medically approved methods. These configurations enable adaptation to diverse uterine anatomies, surgical approaches including open, laparoscopic, or robotic procedures, and varying clinical scenarios, while maintaining effective and reproducible hemostatic compression suturing.
[0048] BEST MODE: In a representative real-world implementation, the automated P-suture hemostatic compression suturing device is employed during a cesarean delivery in a patient diagnosed antenatally with placenta accreta spectrum and assessed to be at high risk of severe uterine hemorrhage. Immediately following fetal delivery and cord clamping, the device is prepared as a sterile, single-use system and positioned adjacent to the operative field. The compression filament is introduced through predefined lateral regions of the uterine myometrium under direct visualization, using the integrated penetration and routing mechanism to ensure accurate placement while avoiding major vascular structures.
[0049] Once the filament has been routed, automated tensioning is initiated through the control unit to achieve a standardized mechanical approximation of the uterine walls. This initial compression is applied prior to placental manipulation in order to reduce uteroplacental blood flow and stabilize the surgical field. The applied compression is maintained within predefined limits, based on real-time feedback from the device, to ensure effective hemostasis without excessive tissue stress.
[0050] Partial placental tissue removal is then undertaken. During this phase, the device maintains sustained compression, thereby minimizing active bleeding from exposed implantation sites. Following removal of accessible placental tissue, the compression level is adjusted through the control unit to reinforce hemostasis, compensating for changes in uterine volume and tissue compliance. The locking mechanism secures the compression filament in position, allowing the device to maintain stable uterine approximation without continuous manual intervention.
[0051] In cases where definitive hysterectomy is deferred or avoided, the maintained compression enables preservation of uterine integrity and supports conservative management strategies. Where ongoing care is required at a higher-level facility, the device remains in a secured state, providing continued hemorrhage control during patient transfer from a peripheral hospital to a tertiary care center. The sustained mechanical stabilization reduces the risk of recurrent bleeding during transport.
[0052] The device is compatible with open surgical access and may alternatively be deployed using laparoscopic or robotic assistance, depending on available infrastructure and clinical preference. Upon completion of definitive management, the device is disengaged or removed in accordance with standard surgical protocols and disposed of as a single-use sterile system. This implementation demonstrates a practical and reproducible manner of carrying out the present invention in a real clinical setting, achieving rapid hemorrhage control, reduced blood loss, and improved procedural safety in patients with placenta accreta spectrum.
[0053] Working of the invention: The automated P-suture hemostatic compression device operates as an integrated mechanical system configured to deploy, route, tension, and secure a biocompatible compression filament along a predefined uterine pathway. During use, the filament delivery and routing assembly advances the filament into lateral regions of the uterine myometrium at controlled locations. A bidirectional penetration guidance mechanism directs the filament through one lateral uterine wall in a first direction and through the opposite lateral uterine wall in a reverse direction, thereby forming a standardized compression loop corresponding to a P-suture configuration.
[0054] Penetration depth is regulated by depth-limiting elements that mechanically and, where applicable, electronically restrict filament advancement to the myometrial layer, preventing endometrial or serosal perforation. Once the filament pathway is established, a tension-regulating compression segment incrementally tightens the filament to approximate anterior and posterior uterine walls. The applied compressive force is maintained within predefined limits sufficient to collapse uterine vascular channels and control bleeding while avoiding excessive tissue stress or ischemic injury.
[0055] An anterior ligation and locking mechanism secure the filament after compression is achieved, ensuring stable retention of the applied approximation. Anchoring and alignment members stabilize the filament along uterine curvature and distribute compressive forces uniformly, reducing localized loading and minimizing filament displacement. The compression may be applied, adjusted, or maintained both before and after partial placental tissue removal to accommodate changes in uterine volume and tissue compliance.
[0056] All functional steps of filament deployment, penetration routing, compression tightening, and locking are executed in a predefined sequence by an actuation mechanism coordinated through a control unit. The control unit may receive feedback from sensors monitoring parameters such as penetration depth, tissue contact, or applied tension, enabling real-time regulation of device operation. The device is suitable for open, laparoscopic, or robotic surgical environments and is supplied as a sterile single-use system, thereby providing a reproducible, operator-independent means of achieving uterine hemostasis in placenta accreta spectrum management.
[0057] The following embodiments describe specific, non-limiting configurations of the automated P-suture hemostatic compression suturing device, illustrating its structural features, modes of operation, and clinical applicability in managing placenta accreta spectrum (PAS) and severe uterine hemorrhage. These embodiments are provided to enable a person skilled in the art to practice the present invention without undue experimentation and to demonstrate the full scope of the claimed device.
[0058] Embodiment 1: Pre- and Post-Placental Removal Compression Suturing: In one embodiment, the automated P-suture hemostatic compression device is configured to perform controlled uterine compression suturing both before and after partial placental tissue removal. Prior to placental manipulation, the filament delivery and routing assembly deploys and advances a biocompatible compression filament through opposing lateral myometrial walls in predefined anterior-to-posterior and posterior-to-anterior pathways to form a P-suture loop. The device applies a predefined and regulated tension to the filament, thereby mechanically approximating the anterior and posterior uterine walls and reducing uteroplacental perfusion to limit blood loss during placental dissection. Following partial or complete placental tissue removal, the device permits re-tightening or adjustment of the formed P-suture loop to reinforce hemostasis at exposed bleeding surfaces, enabling staged hemorrhage control while maintaining uterine stability.
[0059] Embodiment 2: Pre-Hysterectomy Hemorrhage Reduction: In another embodiment, the device is configured to apply automated P-suture compression suturing prior to hysterectomy in patients experiencing uncontrolled uterine bleeding. Upon deployment, the compression filament is passed through the myometrium and secured as a P-suture loop, exerting circumferential or targeted uterine wall approximation. This suturing-based compression rapidly reduces active hemorrhage, stabilizes the uterus, and improves operative visibility, thereby reducing transfusion requirements and procedural risk during hysterectomy in severe placenta accreta spectrum cases.
[0060] Embodiment 3: Uterine Preservation in Conservative PAS Management: In a further embodiment, the device is configured to preserve uterine integrity during conservative management of placenta accreta spectrum. The automated formation of standardized P-suture loops applies uniform and symmetric myometrial compression without focal tissue crushing or ischemic injury. This controlled compression suturing supports fertility-preserving strategies, including delayed placental separation or focal placental resection, while maintaining effective hemostasis and reducing the risk of uterine wall tearing associated with manually applied sutures.
[0061] Embodiment 4: Emergency Stabilization and Patient Transfer: In yet another embodiment, the device is configured to provide rapid stabilization of uterine hemorrhage through automated P-suture compression suturing to permit safe patient transfer. Once the compression filament is routed through the myometrium and locked to form a stable P-suture loop, the device maintains sustained hemostatic compression without continuous manual adjustment. This configuration prevents recurrent hemorrhage during patient transport from peripheral facilities to tertiary care centers.
[0062] Embodiment 5: Compatibility with Multiple Surgical Environments: In an embodiment, the device is configured for use in open, laparoscopic, and robotic surgical environments. The filament delivery, penetration guidance, and compression suturing mechanisms are dimensioned to operate through standard surgical access ports and under direct or endoscopic visualization. Automated filament passage, loop formation, and tension regulation enable reproducible P-suture application across different surgical modalities.
[0063] Embodiment 6: Sterile Single-Use Kit Configuration: In a preferred embodiment, the device is provided as a sterile, single-use surgical kit comprising the compression filament, filament delivery and routing components, penetration elements, and locking mechanisms required to form and secure P-suture loops. The single-use configuration ensures predictable suturing performance, eliminates cross-contamination risk, and simplifies compliance with emergency obstetric protocols.
[0064] Embodiment 7: Control Unit and Closed-Loop Regulation: In an embodiment, the device comprises a control unit configured to coordinate filament penetration, bidirectional routing, compression suturing, locking, and sensor-based regulation. Real-time feedback from sensors monitoring filament tension, tissue resistance, and compression stability enables dynamic adjustment of suturing parameters to maintain effective hemostasis within predefined safety limits. This closed-loop regulation ensures consistent P-suture formation while minimizing tissue trauma and operator dependence.
[0065] EXPERIMENTAL RESULTS
[0066] Experimental evaluation of the automated P-suture hemostatic compression device was conducted to validate its deployment accuracy, compression efficacy, tension control, and procedural reproducibility in a simulated uterine model.
[0067] Filament deployment accuracy:
[0068] The filament delivery and routing assembly was tested in a silicone uterine phantom with lateral wall thicknesses of 8-12 mm. Biocompatible compression filaments were advanced through the myometrial walls at predefined target locations. Across ten trials, lateral placement deviation was measured at 0.5-1.2 mm, demonstrating precise filament positioning with minimal variation. Bidirectional penetration guidance reliably reversed filament direction within 0.8-1.0 mm of the intended reversal point.
[0069] Table 1: Filament Deployment Accuracy in Simulated Uterine Tissue
[0070] The above results demonstrate that the filament delivery and bidirectional penetration guidance mechanisms enable accurate and repeatable placement of the compression filament within predefined myometrial regions. The minimal lateral deviation and controlled reversal accuracy confirm reliable filament routing and precise penetration control under simulated anatomical conditions.
[0071] Compression force evaluation: The tension-regulating compression segment was tested using force sensors applied to simulated uterine tissue. Predefined compression thresholds of 1.5 N, 2.0 N, and 2.5 N were applied. Mean compression forces achieved were 1.48 ± 0.05 N, 2.03 ± 0.07 N, and 2.51 ± 0.08 N, respectively, demonstrating accurate force delivery and reproducible compression across multiple deployments. Compression uniformity along the anterior-posterior axis of the phantom was 92-95% of the target force.
[0072] Table 2: Compression Force Regulation Performance
[0073] The above results demonstrate the tension-regulating compression segment consistently achieves predefined compression targets with minimal deviation and high uniformity across the anterior-posterior axis. This confirms the ability of the device to deliver controlled, evenly distributed mechanical compression suitable for standardized hemostatic control.
[0074] Tension adjustment and locking performance: The anterior ligation and locking module were evaluated for re-tightening and secure fixation. The device-maintained filament tension within ±5% of the target for up to 4 hours under simulated tissue relaxation, confirming reliable locking and minimal slippage. Incremental re-tightening tests showed that tension could be increased in 0.2 N steps without compromising filament integrity or tissue contact.
[0075] Table 3: Tension Adjustment and Locking Performance
[0076] The above data indicates that the anterior ligation and locking module maintains stable filament tension over extended durations and allows incremental re-tightening without loss of fixation. These results establish reliable tension retention and controlled adjustability under simulated tissue relaxation conditions.
[0077] Actuation and Control Unit Validation: The actuation mechanism and control unit were tested in sequential and conditional deployment modes. Actuation time for a complete P‑suture cycle ranged from 18-22 seconds, depending on filament length and deployment path. Sensor feedback from pressure and depth transducers enabled real-time adjustment, maintaining penetration depth within 0.5 mm of the target and preventing over-compression. All ten repeated cycles were completed without mechanical failure or misalignment.
[0078] Table 4: Actuation and Control Unit Performance
[0079] DEVICE ADAPTATION TO UTERINE VARIABILITY: The device was evaluated in uterine phantoms of varying curvature (radius 40-60 mm) and wall thickness (8-14 mm). Filament deployment success rate remained above 95%, and compression uniformity exceeded 90% of the target in all tested anatomical variations. This demonstrates adaptability to diverse uterine geometries and clinical scenarios.
[0080] Table 5: Device Adaptability to Uterine Anatomical Variability
[0081] Sterility and single-use kit validation: Fully disposable units and sterile single-use kits were subjected to gamma irradiation at 25 kGy and ethylene oxide sterilization, respectively. Post-sterilization deployment trials indicated no detectable change in mechanical performance or filament integrity. Device components maintained structural and functional reliability for at least 30 days under ambient storage conditions prior to use.
[0082] These experimental results confirm that the automated P-suture hemostatic compression device is capable of accurate filament placement, reproducible and controlled compression, secure locking, and adaptability to varying uterine anatomies, validating the enablement, operability, and effectiveness of the present invention as claimed.
[0083] Table 6: Comparative Technical Advancement of the Automated P-suture Device over Conventional PAS Hemostasis Techniques
[0084] The automated P-suture device provides substantial technical advancements over conventional PAS hemostasis, including enhanced precision, standardized multi-level compression, consistent tension control, real-time safety feedback, reduced procedure time, and improved reproducibility. These improvements collectively ensure safer, faster, and more reliable hemostasis during surgical management of placenta accreta spectrum.
[0085] Thus, the present invention provides a fully automated solution for uterine hemorrhage management in placenta accreta spectrum, combining precise filament placement, controlled penetration depth, and regulated compression force to achieve effective hemostasis while minimizing tissue trauma. Standardized multi-level P-suture loops with uniform circumferential compression, real-time feedback from integrated sensors, rapid deployment, and adaptability to uterine curvature collectively enable consistent and reproducible performance. Compared to conventional manual suturing, these coordinated features reduce procedure time, improve safety, and ensure reliable hemostasis independent of operator skill, addressing limitations inherent in prior methods.
[0086] In a preferred and best mode of implementation, the automated P-suture hemostatic compression device (100) is constructed as a handheld, reusable surgical instrument with a replaceable sterile filament cartridge, configured for intraoperative use during cesarean hysterectomy-avoiding procedures in patients diagnosed with or suspected of placenta accreta spectrum (PAS). The device is dimensioned to be comfortably manipulated by an obstetric surgeon using one hand while the uterus is exteriorized or partially exposed through a laparotomy incision.
[0087] The device housing is preferably manufactured from medical-grade stainless steel (AISI 316L) or anodized aluminum alloy, with internal structural supports formed from polyether ether ketone (PEEK) to ensure sterilizability, mechanical rigidity, and repeated autoclave compatibility. External gripping surfaces are overmolded with medical-grade silicone elastomer to provide slip resistance under blood-contaminated surgical conditions.
[0088] Filament Delivery and Routing Assembly: In the best mode, the filament delivery and routing assembly (102) comprises a single-use sterile cartridge (102-2A) preloaded with a biocompatible compression filament (102-1). The filament is preferably a polyglactin 910 (Vicryl-type) suture of size 1 or 2, optionally incorporating an elastic or shape-memory segment along a central compression portion to permit controlled dynamic tensioning.
[0089] The cartridge includes a curved filament conduit (102-2B) molded from medical-grade polyethylene or PTFE, the curvature of which is pre-set to correspond to the average lateral uterine contour. The distal end of the conduit terminates in an exit nozzle (102-2C) oriented such that, when the device is positioned against the uterine surface, the filament exits approximately 1 cm medial to the lateral uterine border, corresponding to the standard P-suture entry location recognized in obstetric practice.
[0090] Filament advancement is achieved using a micro-gear driven advancement mechanism (102-3) powered by a compact DC motor or stepper motor housed within the device. The advancement mechanism delivers the filament in precisely metered incremental lengths, ensuring reproducible loop geometry across different patients.
[0091] Bidirectional Penetration Guidance and Needle Actuation: The bidirectional penetration guidance mechanism (104) comprises a reversible curved surgical needle fabricated from hardened surgical stainless steel and mounted within a needle guide assembly (104-1A). The needle curvature is selected to traverse the myometrium while avoiding endometrial cavity penetration.
[0092] A directional switching cam (104-1B) is mechanically coupled to the needle guide and is configured to automatically reverse needle orientation following completion of a first penetration pass. This allows the device to execute an anterior-to-posterior penetration on one lateral uterine wall, followed by a posterior-to-anterior penetration on the contralateral wall, thereby forming the characteristic P-suture loop.
[0093] Needle advancement and retraction are driven by a linear actuator or pneumatic piston (104-1C). In a preferred embodiment, pneumatic actuation is employed to provide smooth force application and rapid response while minimizing mechanical shock to uterine tissue.
[0094] Depth-Limiting and Tissue Protection Mechanisms: To prevent excessive penetration and inadvertent injury to the endometrium or serosa, the device incorporates depth-limiting penetration elements (106). These include adjustable mechanical stop collars mounted on the needle shaft, which physically abut the external uterine surface when a predefined penetration depth is reached.
[0095] In addition, sensor-based depth detection is integrated into the penetration actuator, using either force-profile sensing or optical reflectance sensing to detect tissue boundary transitions characteristic of myometrial layers. Data from these sensors is continuously transmitted to the programmable controller to terminate penetration once safe depth limits are reached.
[0096] Tension-Regulating Compression Segment: The compression filament (102-1) includes a tension-regulating compression segment (108) positioned along the anterior uterine surface when the P-suture loop is completed. This segment comprises an elastic tension buffer, such as a silicone-encapsulated spring element or shape-memory alloy coil, coupled with a force-limiting clutch mechanism.
[0097] During tightening, the clutch disengages automatically once a preset compressive force threshold is achieved. This threshold is selected based on empirical uterine perfusion studies to ensure sufficient compression of arcuate and spiral arterioles at the placental bed while avoiding ischemic injury to the myometrium.
[0098] The elastic buffer further compensates for uterine size changes following placental tissue removal, maintaining constant circumferential compression without progressive tightening.
[0099] Ligation, Locking, and Re-Tightening Module: Upon completion of filament routing, the anterior ligation and locking module (110) is automatically engaged. This module includes a filament clamp (110-1) fabricated from hardened polymer or stainless steel, a knot-forming guide (110-2) that directs the filament into a standardized ligation loop, and a locking latch (110-3) that prevents retrograde filament movement.
[00100] The locking latch is preferably a ratcheting or wedge-based mechanism, allowing incremental re-tightening if required after placental tissue excision while preventing loosening under uterine recoil forces.
[00101] Anchoring, Alignment, and Force Distribution: Anchoring members (112) are positioned along the filament path and comprise soft atraumatic pads molded from silicone or polyurethane foam. These pads gently grip the uterine serosa and distribute compressive force over a broader surface area, minimizing focal tissue stress.
[00102] Alignment members include curved guide rails integrated into the device housing, the curvature of which conforms to the uterine contour. These rails ensure symmetric placement of the P-suture loop on both lateral uterine walls, thereby achieving uniform anterior-posterior wall approximation.
[00103] Sensors, Control System, and Communication: The device further includes a sensor array (116) comprising pressure sensors, strain gauges, tissue contact sensors, and depth sensors positioned at strategic locations along the needle guide, filament path, and compression segment.
[00104] All sensors are electrically connected via shielded micro-cabling to a programmable controller (114-1) housed within the device. The controller executes a predefined control sequence comprising filament deployment, penetration, routing, tightening, and locking. Real-time sensor feedback is continuously analyzed to dynamically regulate penetration depth and compression force.
[00105] The controller communicates with the actuation mechanisms via closed-loop control signals, ensuring repeatable and standardized execution independent of surgeon suturing skill.
[00106] Real-World Surgical Use by Doctors: In actual clinical use, the surgeon exposes the uterus and identifies the lateral entry regions corresponding to the intended P-suture location. The device is placed against the uterine surface, and upon activation, automatically performs the complete P-suture sequence. If additional compression is required, the surgeon repositions the device at higher uterine levels or applies additional loops, including optional cervical encirclage compression. The standardized automation significantly reduces procedure time, blood loss, and operator variability, while preserving uterine integrity and fertility where clinically appropriate.
[00107] Through the coordinated interaction of the filament delivery system, penetration guidance, depth limitation, tension regulation, and sensor-controlled actuation, the device reliably reproduces a clinically validated P-suture compression pathway. This results in effective hemostasis at hemorrhagic placental bed regions, consistent compression of arcuate and spiral arterioles, and controlled uterine wall approximation without ischemic injury.
Claims
1. An automated P-suture hemostatic compression device (100) for controlling uterine hemorrhage associated with placenta accreta spectrum (PAS), the device (100) comprising: a filament delivery and routing assembly (102) configured to deploy a biocompatible compression filament (102-1) through lateral myometrial walls of a uterus at a predefined location approximately medial to a lateral uterine border; a bidirectional penetration guidance mechanism (104) configured to automatically guide the compression filament (102-1) in an anterior-to-posterior myometrial pass on a first lateral uterine wall and a posterior-to-anterior myometrial pass on an opposite lateral uterine wall, thereby forming a P-suture compression loop; a plurality of depth-limiting penetration elements (106) operatively associated with the penetration guidance mechanism and configured to restrict filament penetration to a controlled myometrial depth while avoiding endometrial and serosal perforation; a tension-regulating compression segment (108) integrated with the compression filament (102-1) and configured to automatically apply a predefined compressive force sufficient to approximate anterior and posterior uterine walls and compress arcuate and spiral arterioles at hemorrhagic placental bed regions without causing ischemic injury; an anterior ligation and locking module (110) configured to automatically secure the compression filament (102-1) at an anterior uterine surface after completion of the bidirectional filament pathway; anchoring and alignment members (112) configured to stabilize the compression filament (102-1) along uterine curvature and maintain uniform circumferential compression; and an actuation mechanism (114) operatively coupled to the filament delivery and routing assembly (102), the penetration guidance mechanism (104), and the tension-regulating compression segment (108), the actuation mechanism (114) being configured to automatically execute filament deployment, penetration routing, compression tightening, and locking in a predefined sequence; whereby the device (100) automatically reproduces a standardized P-suture compression pathway to approximate anterior and posterior uterine walls, compress arcuate and spiral arterioles, and achieve hemostasis in placenta accreta spectrum independent of surgeon-controlled suturing.
2. The device (100) as claimed in claim 1, wherein the filament delivery and routing assembly (102) comprises: a filament storage cartridge (102-2A), a guided filament conduit (102-2B), and an exit nozzle (102-2C), the conduit being curved and dimensioned to guide the compression filament (102-1) along a predefined lateral uterine entry trajectory, wherein the exit nozzle (102-2C) is oriented to position the filament entry point approximately one centimeter medial to a lateral uterine border; and a filament advancement (102-3) drive configured to advance the filament in controlled incremental lengths.
3. The device (100) as claimed in claim 1, wherein the bidirectional penetration guidance mechanism (104) comprises: a reversible needle guide (104-1A), a directional switching cam (104-1B), and a penetration actuator (104-1C) configured to perform an anterior-to-posterior penetration on one lateral uterine wall and a posterior-to-anterior penetration on an opposite lateral uterine wall, wherein the directional switching cam automatically reverses penetration orientation after completion of a first penetration pass; and a linear drive (104-2A), rotary cam (104-2B), or pneumatic piston (104-2C).
4. The device (100) as claimed in claim 1, wherein the depth-limiting penetration elements (106) comprise: penetration stop collars fixed to a needle shaft, wherein the penetration stops collar contact an outer uterine surface to mechanically limit penetration depth, and wherein the penetration stop collars are adjustable to accommodate varying myometrial thickness; and sensor-based depth detection integrated with the penetration actuator.
5. The device (100) as claimed in claim 1, wherein the compression filament (102-1) comprises polyglactin, polydioxanone, polyglycolic acid, shape-memory alloy, or composite material.
6. The device (100) as claimed in claim 1, wherein the tension-regulating compression segment (108) comprises: an elastic tension buffer and a force-limiting clutch, wherein the elastic tension buffer absorbs excessive tightening force, and wherein the force-limiting clutch disengages filament tightening when a preset compression threshold is reached, and the compression segment maintains constant compression despite uterine size variation.
7. The device (100) as claimed in claim 1, wherein the anterior ligation and locking module (110) comprises a filament clamp (110-1), a knot-forming guide (110-2), and a locking latch (110-3), and wherein the knot-forming guide (110-2) directs the filament into a predefined ligation loop, and herein the locking latch (110-3) prevents loosening of the ligated filament, and wherein the ligation module is configured to allow re-tightening after placental tissue removal.
8. The device (100) as claimed in claim 1, wherein the predefined compressive force is sufficient to control bleeding while preventing uterine ischemia; and the device (100) is configured to: apply multiple P-suture compression loops at different uterine levels from lower uterine segment to fundus; and apply one or more additional compression loops on cervical tissue using a circular or encirclage-type pathway.
9. The device (100) as claimed in claim 1, wherein the anchoring members comprise soft atraumatic pads configured to grip uterine serosa, the pads distribute compressive force uniformly, the alignment members comprise curved guide rails conforming to uterine curvature, and the guide rails ensure symmetric placement of the P-suture loop.
10. The device (100) as claimed in claim 1, the device (100) further comprising sensors (116) selected from pressure sensors (116-1), depth sensors (116-2), tissue contact sensors (116-3), strain gauges (116-4), or optical sensors (116-5), and wherein sensor feedback dynamically regulates compression force and penetration depth, and wherein the sensors (116) prevent excessive tightening after placental tissue removal.
11. The device (100) as claimed in claim 1, wherein the actuation mechanism (114) comprises a programmable controller (114-1), a drive motor (114-2), and mechanical linkages (114-3) connected to the filament delivery assembly (102), penetration guidance mechanism (104), compression segment (108), and ligation module (110), the programmable controller (114-1) executes a predefined sequence comprising filament deployment, penetration, routing, tightening, and locking, and the programmable controller (114-1) receives sensor feedback to modify penetration depth and compression force in real time.
